Conor McNamara

Stock Analyst at RBC Capital

(1.28)
# 3,648
Out of 5,042 analysts
141
Total ratings
34.95%
Success rate
-11.89%
Average return

Stocks Rated by Conor McNamara

Bio-Techne
Sep 3, 2025
Upgrades: Outperform
Price Target: $61$73
Current: $65.91
Upside: +10.77%
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7$5
Current: $3.41
Upside: +46.63%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251$255
Current: $192.51
Upside: +32.46%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4$3
Current: $1.63
Upside: +84.05%
Exact Sciences
Aug 7, 2025
Maintains: Sector Perform
Price Target: $54$46
Current: $64.64
Upside: -28.84%
Hologic
Aug 6, 2025
Upgrades: Outperform
Price Target: $72$87
Current: $73.99
Upside: +17.58%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20$17
Current: $15.40
Upside: +10.39%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118$126
Current: $100.11
Upside: +25.86%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387$409
Current: $339.75
Upside: +20.38%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387$409
Current: $343.83
Upside: +18.95%
Maintains: Outperform
Price Target: $193$204
Current: $166.33
Upside: +22.65%
Maintains: Outperform
Price Target: $651$637
Current: $572.50
Upside: +11.27%
Reiterates: Outperform
Price Target: $250
Current: $223.01
Upside: +12.10%
Maintains: Outperform
Price Target: $64$61
Current: $30.51
Upside: +99.93%
Maintains: Outperform
Price Target: $8$7
Current: $4.25
Upside: +64.71%